{"id":44659,"date":"2020-01-17T00:00:00","date_gmt":"2020-01-16T23:00:00","guid":{"rendered":"https:\/\/techma.bakertilly.es\/towa-compra-pensa-de-esteve-por-320me\/"},"modified":"2025-03-12T11:49:06","modified_gmt":"2025-03-12T10:49:06","slug":"towa-compra-pensa-de-esteve-por-320me","status":"publish","type":"post","link":"https:\/\/techma.bakertilly.es\/en\/towa-compra-pensa-de-esteve-por-320me\/","title":{"rendered":"Towa buys Pensa for \u20ac320M"},"content":{"rendered":"

Japanese pharmaceutical company\u00a0Towa Pharmaceutical<\/strong>\u00a0and the Catalan\u00a0Esteve<\/strong>\u00a0today announced an agreement under which Towa will acquire the 100% from\u00a0Pensa Investments<\/strong>.<\/p>\n

This is the Spanish pharmaceutical company's generics division.<\/p>\n

The transaction will be carried out for \u20ac320 million.<\/p>\n

The acquisition is expected to be completed by the end of January 2020.<\/p>\n

Corporate finances and movements in the sector are gradually showing the general shift in direction that has been looming for years in the generic drug industry.<\/p>\n

Towa Pharmaceutical<\/a> is a Japanese pharmaceutical company, which has recently acquired the 100% of\u00a0Pensa Investments<\/strong>belonging to the Spanish pharmaceutical company Esteve<\/a>by\u00a0320M\u20ac.<\/strong><\/p>\n

This generics division accounts for a third of the Spanish group's revenues, but it is an operation that forms part of its strategic plan.<\/p>\n

La acquires<\/a> will be paid in a single upfront cash payment and will be fully closed before the end of January.<\/p>\n

<\/span>INTERNATIONAL EXPANSION<\/span><\/h2>\n

With the acquisition of the Catalan company, Towa<\/a> will be able to supply high quality, value-added generic medicines to patients not only in Japan, but also worldwide.<\/p>\n

It will do so through the production platform specialising in \"pellets<\/em>\"Pensa and its network of subsidiaries in Europe and the USA.<\/p>\n

In this way, the Japanese firm is beginning to lay the foundations for large-scale international expansion.<\/p>\n

In fact, it aims to build a solid global structure that respects and integrates the human resources, culture and technologies of each party.<\/p>\n

<\/span>TOWA PHARMACEUTICAL<\/span><\/h2>\n

Headquartered in Kadoma, Kadoma-based Towa Pharmaceutical, a listed is dedicated<\/strong> since 1951 to research, development, production and marketing of generic medicines<\/strong>.<\/p>\n

It has a team of more than 3,100 employees, and its total sales amount to 105,104 million Yen, some \u20ac867 million.<\/p>\n

<\/span>PENSA INVESTMENTS<\/span><\/h2>\n

Pensa Investment is the legal entity that provides affiliated pharmaceutical manufacturing facilities.<\/strong>.<\/p>\n

Founded in 2006, Pensa currently employs around 850 people, 500 of whom work in production and operations.<\/p>\n

It is present in 11 countries around the world such as Turkey and the USA, but especially in European markets such as Spain, Portugal, Italy, Germany and the Netherlands.<\/p>\n

<\/span>ESTEVE<\/span><\/h2>\n

It is based in Barcelona and was founded in 1929.<\/p>\n

It has around 2,300 professionals, and a presence in Europe, the USA, Mexico and China.<\/p>\n

In 2018, it had a turnover of \u20ac758m, with a weight of 73% coming from international markets.<\/p>\n

<\/span>DIVESTMENT PLAN<\/span><\/h3>\n

This operation will allow the company to focus on its \"core business<\/em>\"and accelerate its transformation into an innovative global specialty pharmaceutical company.<\/p>\n

In 2018, as part of its strategic plan, Esteve announced its intention to focus its business on proprietary products and specialised medicine areas.<\/p>\n

The divestment of Pensa was therefore a logical first step in its transformation process.<\/p>","protected":false},"excerpt":{"rendered":"

We analyse from a corporate finance perspective the purchase by the Japanese pharmaceutical company Towa Pharmaceutical of Pensa Investments, the generics division of the Spanish pharmaceutical company Esteve, for \u20ac320m.<\/p>","protected":false},"author":4,"featured_media":44660,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1751],"tags":[152,155,153],"sectores":[],"tipo-contenido":[2260],"class_list":["post-44659","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-adquisiciones-mas-relevantes","tag-compra-de-empresas","tag-corporate-finance-spain","tag-global-corporate-finance","tipo-contenido-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/44659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/comments?post=44659"}],"version-history":[{"count":0,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/44659\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media\/44660"}],"wp:attachment":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media?parent=44659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/categories?post=44659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tags?post=44659"},{"taxonomy":"sectores","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/sectores?post=44659"},{"taxonomy":"tipo-contenido","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tipo-contenido?post=44659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}